Global Sleep Apnea Devices Market – Industry Analysis, Size, Share, Trends and Forecast, 2014 – 2022
Sleep apnea is a severe sleep disorder that occurs when a person’s breathing is disturbed during sleep. People with untreated sleep apnea stop breathing frequently during their sleep. This means the brain and the rest of the body may not get enough oxygen for normal function.
Global Sleep Apnea Devices Market - Industry Analysis, Size, Share, Trends and Forecast, 2014 – 2022
Fig. Global Sleep Apnea Devices Market Projection
Sleep apnea is a severe sleep disorder that occurs when a person’s breathing is disturbed during sleep. People with untreated sleep apnea stop breathing frequently during their sleep. This means the brain and the rest of the body may not get enough oxygen for normal function. There are three types of sleep apnea, namely Obstructive sleep apnea (OSA), Complex sleep apnea and Central sleep apnea. Among these, OSA is the most common of the two forms of apnea and is caused by blockage of airway, generally when the soft tissue in the back of the throat collapses during sleep. Central sleep apnea is less common type, occurs when the brain fails to signal the muscles that control breathing. Whereas, complex sleep apnea is combination of both OSA and central sleep apnea. Treatment options available for sleep apnea include, CPAP, dental devices, implants, surgery and other breathing devices such as Expiratory positive airway pressure (EPAP), Bilevel positive airway pressure (BPAP), and Adaptive servo-ventilation (ASV).
Some of the key factors attributing for an attractive growth of this market include rising awareness among the population about sleep disorders, increasing prevalence of respiratory disorders, growing usage of oral appliances for the treatment, rise in base of aging population, large number of patient population in the emerging countries with unmet medical needs and changing lifestyle habits. The market for global sleep apnea devices was valued at around USD 5.0 billion in 2015 and is expected to reach USD 8.9 billion by 2022, growing at a CAGR of around 8.7% during the forecast period of 2016 to 2022. However, there are certain restraining factors which could hamper the growth of the market, which includes availability of alternative treatment options for the sleep apnea and lack of patient acquiescence.
Geographically, North America is leading contributor to the market and is expected to retain its position during the forecast period due to the presence of large base of geriatric population, favorable reimbursement policies and high adoption of advanced technologies in this region. Nonetheless, the market for Asia-Pacific region is expected to grow at a faster rate owing to growing awareness among the population, and presence of huge patient pool.
The report delivers a strategic analysis of the global market for sleep apnea devices and growth forecast for the period from 2016 – 2022. The scope of the report includes competitive analysis of various market players who are operating in the market, segmental analysis based on type of technology, and products. It also covers geographical analysis of the market with growth forecast for the period of 2016 – 2022. The Porter’s Five Forces analysis and value chain analysis included in the report provides an insight into market dynamics and industry competition.
The study also provides information for recent merger and acquisition deals happened in the global sleep apnea devices market. Moreover, the report also includes growth strategies and entry barriers to be considered to cater to the exact business opportunities in this market. Additionally, to aid in strategic decision making, the report also includes competitive profiling of leading players, recent developments in the industry and various business strategies adopted by them. This report will help players in global sleep apnea market to plan and implement their strategies in different market areas such as emerging geographies, and new technologies
Compumedics Limited GE Healthcare Invacare Corporation Weinmann Medical Devices GmbH Cadwell Laboratories Braebon Medical Philips Respironics Carefusion ResMed and Fisher Paykel Healthcare.